Jul 10, 2026·Score 81·Type A — Value-style analysisUsed for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety.Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology →$62.82
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses.$56.00($54.00–$58.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology →$71.00
Expected Return
Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Type A - Fortive Corporation (FTV) 20260710 Stock Analysis
📅 Fortive Key Upcoming Events
July 29, 2026Q2 2026 Earnings Conference Call
Description: Management is expected to deliver the first full quarter of results reflecting the new “post-spin” corporate structure, providing critical updates on the persistent gross margin impacts from recent U.S. tariffs and the ongoing normalization of the healthcare capital expenditure cycle.
September 1, 2026Launch of eMaint’s Global Partner Network Certification
Description: This strategic initiative aims to scale customer value across industrial maintenance markets by officially launching a partner certification program, which is anticipated to significantly boost the Intelligent Operating Solutions (IOS) segment’s software recurring revenue visibility and global channel penetration.
🏢 Step 1: Fortive Company Overview & Business Model
Q1-A1. What is Fortive?
Company Name (Ticker): Fortive Corporation (FTV)
Sector: Technology
Exchange: NYSE
Founded: July 02, 2016
Listing Date: June 13, 2016
Fiscal Year End: December
Headquarters: United States, Everett
CEO: Olumide Soroye
Market Cap: $19.07B
Shares Outstanding: 304.86M
Current Stock Price: $62.82
Annual Dividend Yield: 0.38% (historical basis)
As-of: July 10, 2026 (ET)
Q1-A2. How Does Fortive Make Money?
Fortive generates highly durable, cycle-resistant revenue by providing mission-critical technologies, software, and services that are fundamentally designed to optimize connected workflows across industrial, commercial, and healthcare environments.
Customers, ranging from global manufacturers to major hospital networks, rely on Fortive for test and measurement instruments, facility lifecycle software, and infection prevention solutions to ensure safety, reliability, and regulatory compliance. The ultimate value proposition is risk mitigation and operational uptime.
Revenue is systematically generated through a highly lucrative hybrid model: direct sales of specialized, industry-standard hardware (e.g., Fluke electronic test tools), high-margin consumables (e.g., sterilization solutions in healthcare), and a rapidly expanding base of recurring software subscriptions (SaaS) and service contracts, which now approach 50% of the overall revenue mix.
Q1-A3. Fortive’s Revenue Segments & Core Income Sources
Intelligent Operating Solutions (IOS) (Approx. 68% of Revenue):
This segment serves as the dominant growth and profitability engine of the company, providing advanced instrumentation, software, and services for facility and asset lifecycle management. With globally recognized iconic brands like Fluke, Gordian, and Accruent, IOS drives the bulk of Fortive’s digital transformation strategy. The segment leans heavily into recurring software revenue and connected worker compliance, generating robust adjusted EBITDA margins that consistently exceed 34%.
Advanced Healthcare Solutions (AHS) (Approx. 32% of Revenue):
Focused entirely on critical clinical workflow solutions, this segment generates reliable income through instrument sterilization, biomedical testing tools, and radiation detection under high-moat brands like Advanced Sterilization Products (ASP) and Censis. The AHS segment acts as a highly defensive growth driver due to its deeply embedded recurring revenue profile, which is heavily weighted toward regulatory-mandated consumables and compliance software, shielding it from traditional macroeconomic volatility.
Q1-A4. Who Are Fortive’s Competitors?
Direct Competitors: Fortive competes in a fragmented landscape of diversified industrial technology and vertical software firms. Key direct rivals include Roper Technologies (ROP), Trimble (TRMB), Keysight Technologies (KEYS), and Cognex (CGNX).
Substitutes and Disruptors: In the enterprise software space, specialized, cloud-native SaaS startups targeting predictive maintenance and asset management pose a theoretical threat. However, Fortive’s deep integration of physical hardware (sensors and diagnostic tools) with proprietary analytics software creates a closed-loop, end-to-end ecosystem that is exceptionally difficult for pure-play software competitors to replicate or displace.
Industry Position: Fortive holds a dominant, often oligopolistic, market share in its specific niche categories (e.g., Fluke is the undisputed global standard in electronic test tools). Following the strategic spin-off of its more cyclical Precision Technologies segment, Fortive is now distinctly positioned as a higher-quality, software-oriented compounder boasting industry-leading gross margins approaching 64%, placing it in the upper echelon of industrial technology peers.
Q1-A5. Fortive Key Events: Past 12 Months
June 28, 2025Completion of Ralliant Spin-Off and CEO Transition
Description: Fortive successfully distributed 100% of its Precision Technologies segment (Ralliant) to shareholders. Concurrently, Olumide Soroye succeeded James Lico as President and CEO, signaling a definitive strategic shift toward accelerating organic growth in software and recurring revenue models while simplifying the corporate structure.
October 29, 2025Aggressive $1 Billion Share Repurchase Execution
Description: Bolstered by the $1.15 billion cash distribution from the Ralliant spin-off, Fortive executed an accelerated $1 billion share buyback, effectively reducing outstanding shares by roughly 6% in a single quarter, reflecting management’s extreme confidence in the company’s intrinsic value.
April 30, 2026Q1 2026 Earnings Beat Amid Tariff Headwinds
Description: The company delivered strong 5.3% core revenue growth and a robust adjusted EPS of $0.70. However, management noted significant gross margin pressures stemming from newly introduced U.S. tariffs on electronic components, which partially offset the operational leverage gained from sales volume.
May 4, 2026Authorization of 20 Million Share Repurchase Program
Description: Demonstrating a relentless commitment to shareholder returns, the Board replenished its general share repurchase authorization with 20 million shares, ensuring continued capital return flexibility following the exhaustion of its post-spin special repurchase capacity.
June 24, 2026ASP Acquires Majority Stake in UV Smart
Description: Expanding its Advanced Healthcare Solutions portfolio, the acquisition of UV Smart bolsters Fortive’s high-level disinfection technology capabilities, driving further consumable integration and recurring service capture within the hospital ecosystem.
Q1-A6. Step 1 Key Takeaways
Step 1 Summary: Fortive has successfully transformed from a diversified industrial conglomerate into a highly focused, software-and-services-led compounder. The company is actively prioritizing resilient, recurring revenue streams while utilizing exceptional free cash flow generation to aggressively buy back its own stock.
Top 3 Red Flags:
1 Heightened exposure to unpredictable U.S. tariff policies, which have caused measurable short-term gross margin contraction.
2 Prolonged budgetary caution in U.S. hospital capital equipment spending, acting as a drag on AHS growth.
3 High insider selling activity, notably from senior executives, relative to open-market purchases.
Top 5 Key Financial/Operational Indicators for Next-Level Analysis:
1 Adjusted Gross Margin trajectory (monitoring the pace of recovery from tariff impacts).
2 Free Cash Flow (FCF) conversion rate (consistently targeting >100% of net income).
3 Software Annual Recurring Revenue (ARR) growth dynamics within the IOS segment.
5 Capital deployment pace (specifically evaluating the share repurchases versus M&A ratio).
Top 3 Unconfirmed and Estimated:
1 The exact timing and magnitude of a full rebound in healthcare capital expenditure budgets.
2 The ultimate structural, long-term impact of recent tariffs if global supply chains cannot be fully re-routed or localized.
3 The long-term integration success and return on invested capital (ROIC) of the recent UV Smart acquisition.
🏰 Step 2: Fortive’s Economic Moat, Growth & Capital Allocation
Q2-A1. Does Fortive Have a Durable Economic Moat?
Entry barriers: Fortive benefits from robust switching costs and deeply entrenched intangible assets. In the AHS segment, healthcare facilities are highly reluctant to alter or replace infection-prevention workflows due to stringent regulatory compliance standards and the catastrophic liability associated with patient safety failures. In the IOS segment, heritage brands like Fluke carry immense, multi-generational brand equity; field engineers and technicians trust these tools implicitly for safety-critical measurements, establishing an insurmountable psychological and operational barrier to entry for unproven, lower-cost competitors.
Pricing Power Verification: Fortive has historically demonstrated exceptional pricing power, driven by the mission-critical nature of its products relative to their remarkably low total cost of ownership. However, recent quarters have exposed mild friction in this pricing mechanism; the company faced a 100-150 basis point gross margin headwind due to sudden geopolitical tariffs that it could not instantaneously pass through to end consumers. Management maintains that net price-to-cost remains positive, indicating that the pricing power is intact but requires time to fully manifest.
Profitability Defense Assessment: The Fortive Business System (FBS) acts as a structural and cultural moat. FBS drives relentless continuous improvement, lean manufacturing disciplines, and structural margin expansion, allowing the company to defend its elite profitability profile (gross margins >60%) across wildly varying macroeconomic cycles.
Q2-A2. Is Fortive’s Growth Sustainable?
Industry Structure and Growth Outlook: Fortive operates within mature but steadily compounding Total Addressable Markets (TAM), which are increasingly supported by powerful, multi-decade secular tailwinds: the electrification of physical infrastructure, the digitization and automation of industrial assets, and the modernization of healthcare workflows. The company methodically targets a sustainable 3-4% core organic growth rate across economic cycles, augmented by M&A.
Growth Sustainability: The strategic transition toward a portfolio mix featuring approximately 50% recurring revenue structurally de-risks future growth. However, this growth trajectory could be structurally halted under three specific downside scenarios:
1 A severe, protracted freeze in U.S. healthcare capital spending that bleeds into consumable purchasing.
2 An unmitigated escalation in global trade wars that significantly raises supply chain costs at a pace that structural pricing adjustments simply cannot match.
3 The failure of newly acquired software platforms to generate anticipated cross-selling synergies or maintain net revenue retention (NRR) rates comfortably above 100%.
Q2-A3. How Does Fortive Allocate Capital & Return Cash?
Priorities and consistency: Management employs a ruthlessly disciplined capital allocation strategy, balancing high-return bolt-on M&A with highly aggressive share repurchases. Over the past twelve months, Fortive deployed roughly $1.8 billion into buybacks, deliberately shrinking the outstanding share float by over 10% post-spin to artificially but effectively compound per-share metrics.
Return on Reinvestment: Fortive historically generates tremendous free cash flow, prioritizing acquisitions that explicitly enhance its software and recurring revenue mix. While the absolute reported Return on Invested Capital (ROIC) appears suppressed (around 5.6%) due to the massive denominator effect of historical goodwill, the incremental cash-on-cash returns on newly invested capital are significantly higher, supported by an FCF margin exceeding 20%. The dividend yield remains minimal (≈0.38%), as cash is preferentially routed to the much more tax-efficient mechanism of share repurchases.
Economic Moat (8/10): Exceptional brand equity and high switching costs provide a formidable moat, though this is slightly offset by recent, proven difficulties in instantaneously passing on tariff-induced inflation.
Growth Sustainability (6/8): Secular tailwinds and a 50% recurring revenue mix provide downside stability, though the organic top-line growth rate remains relatively modest (mid-single digits).
Capital Allocation (7/7): Flawless execution on massive share repurchases at attractive valuations, combined with disciplined, accretive bolt-on M&A that steadily improves portfolio quality.
Step 2 Summary: Fortive possesses a highly durable economic moat built on trusted industrial brands and mission-critical healthcare compliance, complemented by an exceptionally shareholder-friendly capital allocation policy that aggressively reduces the share count to drive per-share value.
💰 Step 3: Is Fortive Profitable? Financial Health Analysis
Q3-A1. Fortive’s Growth & Profitability Trends
Analysis of growth and revenue indicators: Following the Ralliant spin-off, Fortive’s top-line growth algorithm became significantly cleaner and more software-oriented. In Q1 2026, the company reported 7.7% year-over-year revenue growth (5.3% on a core organic basis) to $1.07 billion. More importantly, adjusted EPS surged 25.4% to $0.70. This dynamic clearly indicates that the leaner, post-spin portfolio is highly efficient at translating mid-single-digit sales growth into explosive, double-digit bottom-line expansion, heavily aided by share count reductions.
Profitability margin and leverage verification: While Q1 2026 gross margins contracted slightly (≈100 bps) to roughly 63% due to supply chain tariffs, the Adjusted EBITDA margin expanded to an impressive 29.3%. This confirms that the operating leverage inherent in Fortive’s software-heavy business model remains fully intact; the company is successfully controlling operating expenses to drive bottom-line profitability despite temporary gross margin friction.
Q3-A2. How Profitable Is Fortive? (Margins & ROIC)
ROIC Analysis: Fortive’s headline ROIC sits at approximately 5.62%, which mathematically trails its estimated Weighted Average Cost of Capital (WACC) of 8.1%. However, evaluating Fortive solely on absolute ROIC is fundamentally misleading. This depressed figure is an accounting artifact driven by the massive denominator effect of historical goodwill and intangible assets acquired during its aggressive M&A buildup phase.
Underlying Efficiency: When adjusting for the non-cash drag of historical goodwill, the cash-on-cash operational returns are extraordinarily high, evidenced by an elite Free Cash Flow margin of 21% and gross margins that consistently exceed 60% across both the IOS and AHS operating segments.
Q3-A3. What Drives Fortive’s Returns? (ROIC Breakdown)
Software and Subscription Economy Focus: Given Fortive’s strategic pivot, the critical driver of its capital efficiency is its transition to recurring software and high-margin consumables. The key metric defining this efficiency is the recurring revenue percentage, which now accounts for approximately 50% of total revenue.
Efficiency Logic: By migrating traditional hardware customers into sticky software ecosystems (e.g., connected worker safety applications and predictive maintenance SaaS), Fortive effectively locks in Net Revenue Retention (NRR) rates that typically exceed 100%. This model generates high-margin, compounding cash flows without the corresponding need for intensive physical capital reinvestment, inherently driving up incremental capital efficiency over time.
Q3-A4. Are Fortive’s Earnings High Quality?
Cash Flow vs. Net Income: Fortive exhibits pristine, unassailable earnings quality. In Q1 2026, the company generated $220 million in operating cash flow and $194 million in free cash flow, figures that vastly exceed the GAAP net earnings of $136 million.
Cash Conversion Trend: The Free Cash Flow to Net Income conversion rate consistently exceeds the 100% threshold (averaging between 105% and 109% over the past trailing twelve-month periods). This conclusively demonstrates that Fortive’s reported profits are overwhelmingly backed by actual, liquid cash inflows rather than aggressive accounting accruals or aggressive revenue recognition schedules.
Q3-A5. Is Fortive’s Balance Sheet Healthy? (Debt & Leverage)
Comprehensive Financial Stability: Fortive maintains a fortress-like, investment-grade balance sheet, affirmed by a ‘BBB’ rating from S&P. The company proactively manages its debt maturity wall, recently issuing new corporate bonds due in 2031 and 2036 specifically to extinguish near-term 2026 maturities, virtually eliminating any short-term refinancing risk in a volatile interest rate environment.
Leverage adequacy analysis: The Debt-to-EBITDA ratio currently stands at a highly manageable 2.93x. Management targets maintaining leverage strictly within the 2.0x to 3.0x range, providing them with ample operational firepower to pursue aggressive share buybacks or opportunistic M&A without threatening corporate solvency.
Profitability·Capital Efficiency (7/10): Exceptional EBITDA margins and a highly lucrative software mix justify a strong score, but the absolute ROIC figure remains mechanically depressed due to legacy goodwill, preventing a perfect rating.
Cash Flow·Profit Quality (8/8): Elite FCF conversion rates that consistently exceed 100% of net income validate absolutely pristine earnings quality.
Financial Soundness·Debt Management (5/7): Solid investment-grade metrics and proactive debt refinancing demonstrate strength, though absolute debt levels remain moderately elevated due to the recent pace of massive capital returns.
Step 3 Summary: Fortive operates a highly cash-generative, cycle-tested model with pristine earnings quality, where a growing mix of software recurring revenue drives exceptional cash conversion that fully supports its leverage and aggressive buyback strategies.
Evidence: A rigorous cross-checking of SEC filings (10-K/10-Q) reveals standard SaaS and hardware point-in-time recognition policies, with deferred revenue structures clearly and transparently matching actual cash inflows.
Cost capitalization: not found
Evidence: Software development costs are capitalized strictly within established GAAP boundaries, and there is no sudden, unexplained inflation of intangible asset balances outside of clearly disclosed M&A activities.
Sharp increase in accounts receivable and inventory: not found
Evidence: Days Sales Outstanding (DSO) and inventory turnover metrics remain remarkably stable; supply chain optimizations driven by FBS have actually improved working capital efficiency in recent quarters.
Non-recurring adjustment (normalization): not found
Evidence: While the company frequently utilizes Non-GAAP adjustments for the amortization of acquired intangibles and restructuring costs (which is entirely standard for a serial acquirer), the adjustments are highly transparent, historically consistent, and do not obscure the core cash-generating reality of the business.
Q4-A2. Is Fortive Overspending? (Capex & Capital Cycle)
➖ Not applicable: Fortive’s asset-light business model (heavily weighted toward software and intellectual property) requires minimal CapEx (amounting to only ≈$110 million over the trailing twelve months). This structural advantage entirely isolates the company from traditional industrial overcapacity and capital overheating cycles.
Q4-A3. How Sound Is Fortive’s Cash Flow?
Checking the quality of profits: Operating Cash Flow consistently and dramatically outpaces GAAP Net Income. There are absolutely no fictitious gains; cash flow is generated organically and directly from core operations, heavily supplemented by the upfront collection of deferred revenue from SaaS subscriptions.
Cash flow stability and dependence: Cash flow generation is incredibly resilient across varying economic cycles. Fortive funds its dividends, debt servicing, and aggressive share buybacks entirely from internal FCF generation, avoiding any dangerous reliance on external financing for operational continuity.
Q4-A4. Is Fortive Diluting Shareholders?
Confirmed (Past) Dilution: Outstanding shares have drastically decreased, shrinking by over 10% since mid-2025 due to the massive execution of corporate buyback authorizations. Dilution is decidedly negative; shareholder value is actively compounding through aggressive share concentration.
Potential (Future) Dilution & Overhang: While Stock-Based Compensation (SBC) exists to align management incentives, it is neutralized multifold by the active 20-million share repurchase program authorized in May 2026, ensuring that creeping dilution overhang is structurally impossible.
Q4-A5. Data Integrity Check
Period: FY2025 and TTM Q1 2026 ➡ (Pass)
Definition: GAAP and Non-GAAP metrics are reconciled flawlessly; FCF is consistently and conservatively defined as Operating Cash Flow minus CapEx ➡ (Pass)
Number of shares: Diluted shares are utilized for all per-share metrics, accurately reflecting the recent massive buyback retirements ➡ (Pass)
Unit: USD, unified across absolute and millions/billions terminology ➡ (Pass)
Accounting anomalies/distortion signals (8/8): Exceptionally clean reporting, consistent GAAP to Non-GAAP bridges, and highly transparent M&A accounting.
Cash flow warning signals (7/7): Cash generation is pristine, easily covering all capital allocation obligations without any external reliance.
Dilution factors (5/5): The company is a massive net retire-er of shares at an aggressive pace, completely eliminating any threat of equity dilution.
Step 4 Summary: Fortive’s forensic profile is impeccable; its cash flow perfectly aligns with reported earnings, and the company is aggressively retiring shares rather than diluting existing shareholders.
Q5-A1. Can You Trust Fortive’s Management? (Guidance Track Record)
Guidance Hit Rate: Fortive’s management, led by CEO Olumide Soroye, maintains a stellar “beat-and-raise” track record. The company consistently meets or exceeds the midpoint of its conservative guidance, as seen in the recent Q1 2026 earnings surprise where adjusted EPS of $0.70 comfortably beat consensus expectations of $0.64.
Transparency and Consistency: Management communicates with high transparency, directly addressing headwinds such as tariff-induced margin pressures while clearly mapping the path to mitigation via pricing power and Fortive Business System (FBS) operational efficiencies. They do not hide behind macroeconomic excuses.
Q5-A2. What Are Fortive Insiders Doing?
Insider Trading Status and Context Analysis: A detailed review of recent SEC Form 4 filings indicates a strong, ongoing trend of insider selling. Most notably, SVP and Chief Legal Officer Peter Underwood sold 47,557 shares in May 2026 for approximately $2.89 million at an average price of $60.81. This transaction followed a mechanical options exercise. Over the past 12 months, aggregate insider sales have outpaced purchases by roughly $14 million.
Evaluating executive confidence signals: While there are no recent open-market cluster buys from executives to signal extreme undervaluation confidence, the heavy corporate-level share buyback program ($1.8 billion retired recently) effectively acts as a proxy for management’s belief that the stock remains attractively priced. The personal executive sales appear largely tied to routine portfolio diversification and option expirations rather than a fundamental lack of faith in the company’s trajectory.
Q5-A3. Is Fortive’s Management Aligned With Shareholders?
Voting Rights and Governance Check: Fortive maintains a clean, shareholder-friendly single-class share structure (one share, one vote), ensuring equitable treatment for all general shareholders with no dual-class entrenchment mechanisms.
Performance and Compensation Indicator (KPI) Analysis: Executive compensation is heavily weighted toward performance-based equity (PSUs and RSUs) that are intrinsically tied to core organic growth, adjusted operating margin expansion, and free cash flow generation. This structure directly incentivizes the optimization of cash returns over mere empire-building.
Incentive alignment assessment: The alignment is highly robust. Management’s relentless focus on executing the “Fortive Accelerated” strategy has resulted in a leaner, higher-margin portfolio, directly rewarding shareholders through massive equity retirements rather than executive bloat.
Management Trust (5/5): Impeccable credibility backed by a flawless post-spin track record of consistently meeting and raising financial guidance.
Insider Trends (3/5): While the corporate buyback is massive, personal insider transactions lean heavily toward sales (e.g., the recent $2.89M sale by the CLO), dampening the psychological momentum signal.
Governance & Compensation System (4/5): Clean single-class structure with KPIs appropriately tied to FCF and margin expansion.
Step 5 Summary: Management is highly credible and aligned structurally with long-term shareholder value creation, though the lack of personal insider open-market buying tempers the momentum signal slightly.
⛵ Step 6: Fortive Market Flow & Sentiment
Q6-A1. Analyst Consensus vs Fortive Guidance
Guidance gap and direction analysis: Management explicitly reaffirmed their FY 2026 Adjusted EPS guidance of $2.90 to $3.00, noting they are “currently trending toward the upper half of the range”. The broader market consensus for FY 2026 EPS sits precisely at $3.00. This indicates that market expectations are perfectly aligned with the most optimistic edge of management’s own guidance, leaving very little room for execution error.
Tracking recent sentiment changes: Over the past 90 days, analyst sentiment has stabilized around a cautious “Hold” consensus. Following the Q1 earnings beat, firms like Truist raised price targets (e.g., $61 to $67), reflecting growing confidence in the company’s defensive characteristics and software pivot, though significant upgrades remain scarce.
Q6-A2. What Is Fortive’s Short Interest?
Institutional Trends: Institutional ownership remains exceptionally high at over 103% (indicating significant short interest overlap or reporting delays), showcasing that Fortive is viewed as a mandatory core holding for large-cap industrial/tech funds.
Short Selling Indicators: Short interest represents 5.00% of the outstanding float, with a days-to-cover ratio of 4.59 days. This is a moderate, easily digestible level of short interest—neither a strong bearish signal nor sufficient to trigger a violent short squeeze in the event of a sudden price spike.
Consensus vs Guidance (2/3): Market consensus sits at the absolute high-end of management’s guidance, indicating strong expectations but severely limiting surprise upside.
Supply/Short Interest (1/2): Institutional backing is solid, but the 5.0% short interest ratio indicates a neutral, slightly cautious market undercurrent.
Step 6 Summary: Market sentiment is currently constructive but demanding, with consensus estimates already fully pricing in execution at the upper bound of management’s targets.
🚀 Step 7: Fortive Catalysts & Price Triggers
Q7-A1. What Could Move Fortive Stock? (Top 3 Catalysts)
1 Accelerated realization of hardware-to-software cross-selling synergies in the IOS segment
Timing: Next 6-12 months
Success Conditions: The iconic Fluke and Accruent brands successfully convert legacy hardware users into sticky SaaS subscribers, expanding Net Revenue Retention (NRR) significantly beyond current levels.
Failure Risk: Enterprise customers resist SaaS conversion due to macroeconomic budget constraints, stalling the recurring revenue growth narrative.
2 Normalization of U.S. hospital capital expenditure cycles
Failure Risk: Prolonged budgetary caution limits AHS growth strictly to required consumables and mandatory software updates, delaying top-line acceleration.
3 Strategic deployment of remaining balance sheet capacity for accretive M&A
Timing: Next 6-12 months
Success Conditions: Leveraging its 2.9x Debt/EBITDA leverage and massive FCF, management executes a high-margin software acquisition similar to the UV Smart deal, instantly upgrading overall TAM.
Failure Risk: M&A discipline slips in a high-valuation market, resulting in overpayment for an asset that dilutes overall ROIC.
Q7-A2. Fortive’s Earnings Revision Trend
Tracking EPS estimate changes: Following the impressive Q1 2026 earnings beat ($0.70 vs. $0.64 estimate), Wall Street initiated modest upward revisions. Analysts adjusted the FY 2026 EPS consensus upwards to $3.00, reflecting a 10.6% year-over-year expected growth rate.
Earnings expectations and momentum assessment: The revision momentum is positive but heavily contained. The market is actively rewarding Fortive for its defensive resilience and massive buybacks, but analysts await definitive proof that tariff headwinds are fully mitigated before initiating aggressive, cycle-breaking upgrades.
Catalyst (5/7): High probability of recurring revenue expansion and continued M&A execution, though external macro dependencies (like hospital budgets) remain a persistent drag.
EPS Trend (2/3): Revisions are trending upward post-earnings, but overall expectations are highly calibrated and tethered to existing guidance.
Step 7 Summary: The primary catalysts driving future stock appreciation lie in Fortive’s internal ability to compound recurring software revenue and efficiently deploy capital, supported by a mild upward trajectory in earnings revisions.
⚖️ Step 8: Is Fortive Fairly Valued? Valuation Analysis
Scoring Rationale: The absolute valuation metrics present a highly mixed picture. While trailing GAAP PE and PS ratios appear bloated due to historical accounting, the Forward PE and Cash Flow-based metrics (P/FCF and EV/EBITDA) settle into a highly reasonable ≈19x–20x range, which is perfectly standard (fairly valued) for a high-quality software-industrial compounder.
📌 (1) Axis Q8-A1 Score:0
Q8-A2. Fortive vs Peers: Valuation Comparison
Multiple selection based on peer comparison: Forward PER
Calculation of peer-to-peer deviation rate: -8.45%
🧮 Calculation Formula: ((20.14 - 22.00) / 22.00) × 100 = -8.45% (Based on a blended benchmark of core peers like ROP, KEYS, and TRMB averaging ≈22x Forward P/E)
Scoring Rationale: Fortive trades at a slight discount (-8.45%) to the average multiple of its direct peer group. This discount is not deep enough to scream undervalued, reflecting a squarely Fairly Valued status within the industry context.
📌 (2) Axis Q8-A2 Score:0
Q8-A3. Is Fortive Cheap or Expensive vs Its History?
Comparison Indicators: Trailing P/FCF
Scoring Rationale: Over the past 5 years, Fortive has historically commanded extreme premium multiples as it transitioned toward software. Trading at a P/FCF of roughly 19.7x places the company in the bottom 20-40% of its historical 5-year valuation band (which frequently exceeded 25x FCF). This relative historical compression indicates it is undervalued relative to its own past.
📌 (3) Axis Q8-A3 Score:+2
Q8-A4. What Growth Is Priced Into Fortive? (Reverse DCF)
Implied Growth Rate:6.0%
1 Methodology: PEG-based inversion based on current Forward P/E
2 Core assumptions: Requires a steady 6.0% CAGR in free cash flow over the next 5-10 years to completely justify the current $62.82 share price at an 8.1% WACC.
Achievable Growth Rate:8.79%
Basis: Latest 3-year Wall Street consensus EPS growth forecast.
Scoring Rationale: The market is currently pricing in a highly achievable 6.0% growth rate. Given Fortive’s forecasted near 9% EPS growth fueled by massive share repurchases and software operating leverage, the company should comfortably exceed these expectations, presenting a slight undervaluation gap.
(3) Axis Q8-A3 (Historical Band Position): Undervalued
(4) Axis Q8-A4 (Justification for Growth): Undervalued
The analysis yields a 2:2 split (two axes point to Fair Valuation, two point to Undervaluation). Because there is no majority consensus (at least 3 directional matches), a conservative directional mismatch penalty is automatically triggered.
📌 (5) Axis Q8-A5 Score:-2
Q8-A6. Fortive’s Asset & Stake Valuation
Scoring Rationale: ➖ Not Applicable. Fortive is an operating technology company, not an asset holding entity or conglomerate dependent on SOTP/NAV discounts.
📌 (6) Axis Q8-A6 Score:➖
Q8-A7. Final Valuation Adjustment
Scoring Rationale: There are no exceptional fundamental paradigm shifts or extraordinary structural anomalies that warrant overriding the mechanical valuation results. The company is operating exactly as designed.
Commentary: The mechanical valuation models reveal that Fortive is currently trading near its fair intrinsic value. While historical bands and growth forecasts suggest slight undervaluation, the cross-check penalty pulls the overall valuation adjustment back to a highly neutral, marginally positive score.
Step 8 Summary: The current stock price of $62.82 is fundamentally rational and represents a fairly valued entry point without a massive margin of safety.
💀 Step 9: What Are the Risks of Fortive? Fatal Risks & Pre-Mortem
Q9-A1. What Are the Biggest Risks to Fortive?
1 Escalation of U.S. tariff policies causing uncontrollable gross margin degradation:
Cause: Intensifying geopolitical trade wars resulting in higher input costs for hardware components across the IOS segment.
Impact: Financial (Contraction of gross margins below the 60% threshold).
Mitigation/Monitoring Indicators: Quarterly tracking of the ‘Price-to-Cost’ spread (management currently targets maintaining a >1% positive spread).
2 Prolonged stagnation in healthcare capital equipment budgets:
Cause: U.S. hospital networks freezing spending due to severe labor inflation and shifting regulatory pressures.
Impact: Financial (Deceleration of the Advanced Healthcare Solutions segment’s core growth).
Mitigation/Monitoring Indicators: Management commentary on AHS capital order conversion rates versus recurring consumables.
3 Failure to integrate or achieve ROI on high-multiple software acquisitions:
Cause: Overpaying for SaaS bolt-ons that fail to synergize with Fortive’s existing hardware ecosystems.
Impact: Multiple (Reduction in overall ROIC and potential future goodwill impairment charges).
Mitigation/Monitoring Indicators: Monitoring incremental ROIC and software Net Revenue Retention (NRR) metrics.
Q9-A2. How Sensitive Is Fortive to the Economy?
1 Global Trade Tariffs (Regulatory Risks) (⬇): If protectionist policies force immediate supply chain realignment, the hardware components of the IOS segment will face immediate margin pressure before pricing power can fully offset the newly introduced costs.
2 High Interest Rate Environment (Macro Risks) (⬇): Sustained high rates place a firm valuation ceiling on software-centric multiples (Forward P/E) and dampen the capital expenditure appetite of Fortive’s industrial end-users.
Q9-A3. Fortive Pre-Mortem: What Could Go Wrong?
1 The devastating collapse of the industrial digitization narrative: If enterprise customers universally reject the shift from hardware tools to SaaS subscriptions due to tightening macro budgets, Fortive’s high-multiple recurring revenue strategy crumbles, forcing a violent rerating back to traditional industrial hardware multiples.
Early Warning Signal: The IOS segment reports consecutive quarters of software ARR growth dropping below 5%.
2 A disastrously dilutive mega-acquisition destroys capital discipline: Flush with cash, management abandons its high-return bolt-on strategy and acquires a massive, low-margin legacy hardware competitor, destroying the carefully curated post-spin software margin profile.
Early Warning Signal: An unexpected M&A announcement that requires the issuance of new equity or pushes leverage dangerously above 3.5x Debt/EBITDA.
3 Severe regulatory crackdown on healthcare sterilization protocols: If new FDA regulations force a total redesign of the Advanced Sterilization Products (ASP) ecosystem, Fortive would face astronomical R&D costs and a halt in highly lucrative consumable revenues.
Early Warning Signal: FDA warning letters or increased regulatory scrutiny filings related to ASP products.
Q9-A4. Risk Adjustment Score Calculation
📊 Risk Adjustment Score:-4 pts
Reason for Calculation: The primary risks facing Fortive (tariffs and hospital CapEx delays) fall squarely into the -1 to -10 deduction range. These are qualitative and mild quantitative concerns that management has historically proven capable of controlling via pricing adjustments and cost productivity. The risks do not currently threaten the structural survival or liquidity of the business.
Step 9 Summary: Fortive’s risk profile is highly manageable. While short-term gross margin friction from tariffs requires close observation, the exceptionally strong recurring revenue base protects the company from fatal cyclical downturns.
🎯 Step 10: Fortive Final Verdict: Score & Rating
Q10-A1. Investment Score & Rating
Investment Score & Rating:81 pts(B Rating ⭐⭐⭐)
Investment Score Calculation Formula: Sum of scores for Steps 2-7 (83 pts) + Valuation Adjustment Score (2 pts) + Risk Adjustment Score (-4 pts) = Investment Score 81 pts
Commentary: Fortive earns a solid B Rating. The company demonstrates an exceptional forensic profile, pristine cash flow quality, and a highly shareholder-aligned buyback strategy. However, the overall score is kept out of the A-tier due to fair (rather than cheap) valuation multiples, modest organic growth rates, and mild short-term gross margin headwinds from geopolitical tariffs.
Q10-A2. Should You Buy Fortive? (Recommendation)
Recommendation:Hold
Commentary: At the current price, Fortive is an incredibly high-quality compounder trading precisely at its fair intrinsic value. It is a stock to hold tightly for long-term compounding, but investors seeking a deep margin of safety should wait for macro-induced volatility to provide a more attractive entry point.
Q10-A3. Investment Thesis in One Line
Fortive is a cash-printing, software-pivoting compounder aggressively buying back shares, but its current fair valuation and mild tariff-induced margin friction limit immediate explosive upside.
Q10-A4. Fortive’s Price Trend & Key Drivers
Stock Price Trends Over the Past 12 Months:Sideways movement
June 28, 2025Completion of Ralliant Spin-off
Description: The successful execution of the spin-off triggered a widespread re-evaluation of Fortive as a pure-play software and services entity, stabilizing the stock during intense market turbulence. ➡ Stock Price Stabilization
October 29, 2025Massive $1 Billion Share Repurchase Execution
Description: Management deployed massive spin-off proceeds to instantly retire roughly 6% of the float, establishing a mathematically strong fundamental floor under the stock price. ➡ Strong Technical Support Formed
April 30, 2026Q1 2026 Earnings Beat Clouded by Tariff Commentary
Description: Despite heavily beating EPS and EBITDA estimates, management’s acknowledgment of a 100+ basis point gross margin hit from tariffs caused mild investor hesitation and range-bound trading. ➡ Stock Price Sideways Chop
Q10-A5. Action Plan
Current Price:$62.82
Buy Zone:$56.00 ($54.00–$58.00)
Commentary: By comprehensively considering the company’s traditional intrinsic value (safety margin) and current market momentum, we calculate an Actionable Buy Zone that minimizes opportunity costs.
(1) Calculation of Fundamental Value: To secure a true margin of safety against a Forward P/E of ≈20x, we target a multiple compression closer to 17x-18x, which historically acts as a hard, impenetrable floor for software-industrial hybrids.
(2) Momentum Premium/Discount Application: Fortive currently lacks an immediate, explosive near-term growth catalyst (like a hyper-scaler AI contract), meaning we must strictly adhere to a conservative intrinsic value entry without paying any momentum premium.
(3) Conclusion: The calculated $56.00 midpoint represents the level where Fortive’s pristine FCF generation and aggressive buyback yield provide an unassailable margin of safety.
Target Price:$71.00
Expected Return:+13.0% (vs. current price)
📍 Select target stock price calculation criteria:
Forward P/E Multiple — The most accurate and stable proxy for Fortive given its successful transition to predictable, recurring EPS generation.
🧮 Target Price Calculation Formula:
Per share indicator based (Forward PER, P/FCF, etc.): $3.22 × 22.0x = $71.00
Basis for applying the multiple: A 22.0x multiple aligns Fortive perfectly with the average of its high-quality peer group (ROP, TRMB, KEYS) and properly rewards its resilient 50% recurring revenue mix.
Conditions and timing for reaching target price: Achievable over the next 6-12 months, predicated specifically on the company successfully passing through tariff costs to fully restore gross margins above 64% by Q4 2026.
Stop Loss & Investment Thesis Invalidation Criteria:$53.00 ($51.00–$55.00)
Fundamental damage criteria: Consecutive quarters of core organic growth dropping precipitously below 2% or Adjusted EBITDA margins contracting below 27%, signaling that the software pivot has fundamentally failed to offset hardware cyclicality.
Action trigger upon catalyst achievement:
1 Expansion of IOS segment software ARR growth past 15%
Description: This would prove that the hardware-to-software conversion thesis is accelerating, strongly justifying a multiple expansion toward Roper Technologies’ 25x level. 👉 Increased Holdings (Buy)
2 Management successfully neutralizes tariff impacts via pricing in Q3
Description: Confirmation that Fortive’s pricing power remains absolute, clearing the path for uninterrupted operating leverage. 👉 Increased Holdings (Buy)
3 Execution of a large, accretive M&A deal using excess debt capacity
Description: Deploys idle capital into a high-ROIC software asset, instantly boosting out-year EPS estimates. 👉 Hold / Wait for Integration
Action triggers when risk realization:
1 U.S. hospital CapEx completely freezes in 2H 2026
Description: The AHS segment’s hardware sales would plummet, requiring immediate mechanical downgrades to consensus EPS. 👉 Reduction in Holdings (Sell)
2 Gross margins contract for a third consecutive quarter
Description: Proves that Fortive lacks the monopoly power necessary to force end-users to absorb geopolitical supply chain shocks. 👉 Reduction in Holdings (Sell)
Description: Signals internal executive concern regarding upcoming liquidity needs or a lack of faith in the current valuation. 👉 Wait and See
Customized Strategy Guide by Investment Preference:
Defensive Investors: Maintain a core position. The 50% recurring revenue and massive buybacks provide a highly reliable floor, but do not allocate new capital above $60.
Neutral Investors: Hold current shares and employ a patient buy-the-dip strategy if macro-driven selloffs push the price into the $56 zone.
Aggressive Investors: Capital may be better deployed elsewhere for immediate alpha. Fortive is a steady, predictable compounder, not an explosive momentum play.
🕵️♂️ Deep Dive Analysis
Q1: Is Fortive’s Heavy Reliance on Hardware in a Software-Pivoting Strategy Its Biggest Weakness?
Analysis: Fortive is widely lauded for its strategic transformation toward software, rightfully boasting that approximately 50% of its revenue is now recurring. However, the foundational layer of its ecosystem—particularly in the Intelligent Operating Solutions (IOS) segment with iconic brands like Fluke—remains intrinsically linked to the deployment of physical hardware instruments. This dual nature acts as a double-edged sword. While hardware provides the crucial “land” in a land-and-expand strategy, it heavily exposes the company to traditional manufacturing vulnerabilities. As evidenced in Q1 2026, Fortive suffered a 100+ basis point contraction in gross margins directly attributable to U.S. tariff policies on physical components. Pure-play software competitors do not face these severe supply chain and geopolitical margin frictions. If Fortive cannot seamlessly pass these physical hardware costs onto consumers through rapid pricing adjustments, its overall margin expansion narrative—which fundamentally justifies its premium software-like valuation multiple—will encounter severe, structural resistance.
Judgment:Neutral. The hardware dependency is a tangible, measurable weakness regarding supply chain vulnerability and margin friction, but it is simultaneously the ultimate protective moat that prevents pure-play software startups from disrupting Fortive’s established enterprise ecosystem.
Q2: Can Fortive’s 20x Forward P/E Be Justified by the Post-Spin Focus on Recurring Revenue?
Analysis: Following the Ralliant spin-off, Fortive actively shed its more cyclical Precision Technologies exposure, deliberately leaving behind a leaner entity dominated by IOS and AHS. The market has subsequently awarded New Fortive a ≈20x Forward P/E multiple. When comparing this to high-quality industrial software peers like Roper Technologies (which regularly trades closer to 25x), Fortive’s multiple is actually quite conservative. The deep justification for this multiple lies not in explosive top-line growth (which remains at a modest 3-4% organically), but in the pristine, unassailable quality of its earnings. Fortive routinely converts over 100% of its net income into free cash flow, heavily insulated by regulatory compliance software and healthcare consumables. Furthermore, because management aggressively retires the float (reducing shares by over 10% in a year), the per-share intrinsic value compounds at a significantly faster rate than the top-line growth rate suggests.
Judgment:Fairly Valued. The 20x multiple is fully justified by the elite free cash flow conversion and highly defensive recurring revenue base, perfectly balancing the lack of hyper-growth with extreme capital efficiency and downside protection.
Q3: How Will the U.S. Tariff Environment Structurally Impact Fortive’s Gross Margin Profile?
Analysis: The Q1 2026 earnings call highlighted a highly notable headwind: despite strong core revenue growth, consolidated adjusted gross margins dipped to ≈63%, specifically pressured by recently implemented tariff policies on global supply chains. The critical question for long-term investors is whether this is a permanent structural impairment or merely a temporary timing lag. Management aggressively asserts that they are maintaining a positive price-to-cost spread (above 1%) and that the tariff impacts will be fully mitigated by Q4. Given Fortive’s extensive historical track record via the Fortive Business System (FBS) of engineering costs out of the system and commanding absolute pricing power for mission-critical tools like Fluke and ASP, it is highly probable that the margin degradation is transitional.
Judgment:Positive long-term. The friction is real and will mathematically suppress margins through mid-2026, but Fortive’s pricing power and FBS methodologies will ultimately digest and completely offset the costs by year-end, restoring the 64%+ margin profile.
Q4: Will the Ralliant Spin-Off Truly Accelerate Fortive’s Software Annual Recurring Revenue (ARR)?
Analysis: The spin-off of Ralliant was not merely a financial engineering exercise; it was a fundamental reallocation of corporate focus. By removing the capital-intensive, cyclical Precision Technologies segment, executive attention and R&D budgets are now laser-focused entirely on the IOS and AHS segments. This allows Fortive to double down on converting its massive installed hardware base into recurring software subscribers. The acquisition of UV Smart in June 2026 by ASP is a direct result of this sharpened focus, integrating advanced disinfection technologies that drive recurring consumable and service revenue. As management no longer has to dilute its focus managing cyclical industrial components, the velocity of SaaS product rollouts and cross-selling initiatives within IOS is expected to accelerate dramatically.
Judgment:Positive. The simplified corporate structure provides the essential bandwidth and capital required to aggressively scale software ARR, removing the cyclical drag that previously masked the underlying growth of the software portfolio.
Analysis: Fortive has deployed roughly $1.8 billion into share repurchases over the past 12 months, retiring a massive portion of its outstanding float. Critics argue that such aggressive buybacks are a classic hallmark of a mature company masking anemic single-digit organic growth (3-5%). However, this perspective ignores the fundamental capital efficiency of the Fortive model. When a company generates over $1 billion in free cash flow and its core markets only require mid-single-digit capital reinvestment to maintain dominance, hoarding cash or overpaying for M&A destroys value. By repurchasing shares at a ≈20x FCF multiple, Fortive is executing a highly accretive return on capital that mechanically drives 10%+ EPS growth despite modest top-line expansion. It is not masking poor growth; it is optimizing capital structure.
Judgment:Neutral. While top-line organic growth is undeniably modest, the aggressive share repurchases are a highly rational, mathematically accretive use of excess free cash flow that directly drives shareholder value.
Q6: Can Fluke Successfully Capture the Rapidly Expanding AI Data Center Power Testing Market?
Analysis: While Fortive is rarely classified as a direct AI infrastructure play, it is perfectly positioned as a highly lucrative secondary beneficiary. The explosive, multi-billion-dollar buildout of AI data centers requires unparalleled power stability, thermal cooling efficiency, and 100% uptime reliability. Fluke, housed within the IOS segment, is the undisputed global industry standard for electronic test tools and condition monitoring. During recent updates, management specifically called out strong customer response to Fluke’s data center testing products as a major growth driver. As data centers grow exponentially larger and more complex, the critical need for advanced, predictive-maintenance hardware linked to SaaS monitoring platforms will surge, providing a stealthy, high-margin avenue to capitalize on the AI supercycle.
Judgment:Positive. Fluke’s deep integration into data center power maintenance provides a highly lucrative, under-the-radar structural growth vector that perfectly leverages Fortive’s hardware-to-software ecosystem without competing directly in the volatile semiconductor space.
Q7: Are Ongoing Capital Expenditure Freezes in U.S. Hospitals a Terminal Threat to the Advanced Healthcare Solutions Segment?
Analysis: The Advanced Healthcare Solutions (AHS) segment, which accounts for roughly 32% of Fortive’s revenue, relies heavily on hospital networks upgrading their sterilization and biomedical tracking equipment. Recently, severe labor inflation and tightening budgets have caused U.S. hospitals to freeze major capital expenditures, resulting in a noticeable drag on AHS growth. However, while the hardware sales are delayed, the regulatory requirements for infection prevention cannot be deferred. Hospitals must continue purchasing the high-margin consumables and software licenses required to operate their existing ASP and Censis systems. This dynamic ensures that while top-line growth may stall temporarily, the highly profitable recurring revenue floor remains entirely intact.
Judgment:Neutral. The CapEx freeze is a significant short-term top-line headwind, but the deeply entrenched, regulatory-driven consumable revenue prevents any terminal, structural damage to the segment’s profitability.
Q8: Does Fortive’s Depressed 5.6% Return on Invested Capital (ROIC) Accurately Reflect Its Fundamental Capital Efficiency?
Analysis: On paper, Fortive’s headline ROIC sits at a seemingly lackluster 5.62%, which trails its estimated 8.1% Cost of Capital. For a company lauded as a high-quality compounder, this figure appears alarming. However, this absolute ROIC figure is fundamentally distorted by accounting mechanics. Fortive is a serial acquirer; its balance sheet is loaded with billions in historical goodwill and intangible assets from past acquisitions. This massive denominator severely depresses the reported ROIC. When assessing the incremental return on invested capital—the cash-on-cash returns generated by the actual operating businesses today—the efficiency is extraordinary, evidenced by gross margins exceeding 60% and a Free Cash Flow margin of 21%.
Judgment:Positive. The depressed absolute ROIC is a misleading accounting artifact; the underlying operational cash generation and incremental capital efficiency are exceptionally strong and highly accretive.
Q9: Will the Recent UV Smart Acquisition Meaningfully Move the Needle for Fortive’s Infection Prevention Group?
Analysis: In June 2026, Advanced Sterilization Products (ASP) acquired a majority stake in UV Smart, a company specializing in high-level disinfection technology using ultraviolet light. While the financial terms of the deal were likely too small to instantly move Fortive’s consolidated EPS, the strategic implications are profound. UV Smart’s technology allows ASP to expand its footprint beyond traditional chemical sterilization into rapid, chemical-free disinfection protocols, capturing a new segment of the hospital workflow. Furthermore, this hardware will undoubtedly be integrated into Fortive’s recurring service and software compliance ecosystem, ensuring long-term, sticky revenue.
Judgment:Positive. While financially small in the near term, the acquisition perfectly executes Fortive’s strategy of capturing adjacent clinical workflows and converting them into high-margin recurring revenue streams.
Q10: Is CEO Olumide Soroye’s ‘Fortive Accelerated’ Strategy Delivering Tangible Execution Beyond Financial Engineering?
Analysis: Upon taking the helm, CEO Olumide Soroye introduced the “Fortive Accelerated” strategy, promising profitable organic growth, disciplined capital allocation, and a relentless focus on the Fortive Business System (FBS). Critics could argue that the massive $1.8 billion share buyback is merely financial engineering designed to hit EPS targets. However, the Q1 2026 results demonstrate tangible operational execution: 5.3% core organic revenue growth and a 13.2% increase in Adjusted EBITDA despite severe tariff headwinds. The ability to expand EBITDA margins while simultaneously absorbing supply chain shocks proves that FBS is actively engineering costs out of the system, validating that the strategy is built on operational excellence, not just balance sheet manipulation.
Judgment:Positive. The combination of robust core organic growth, margin expansion against headwinds, and aggressive buybacks proves that the ‘Fortive Accelerated’ strategy is delivering highly tangible, fundamentally sound execution across all fronts.